Cite Filings / ROIV / 0000950170-25-020935

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Roivant Sciences Ltd. Filed 2025-02-14 Acc 0000950170-25-020935

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-14 4 President & COO sold 435,425 shares at an average $10.47 ($4,561,041)
2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-13 144 Sale of Securities
2025-02-12 144 Sale of Securities
2025-02-10 10-Q Quarterly Report
2025-02-10 8-K Results of operations

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…